Search Results

CPI-613 25mg 25mg  | Purity Not Available

Adooq Bioscience

CPI-613 is a racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities.

More Information Supplier Page

CPI-613 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

CPI-613 is a racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities.

More Information Supplier Page

CPI-613 10mg 10mg  | Purity Not Available

Adooq Bioscience

CPI-613 is a racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities.

More Information Supplier Page

LX 1606 50mg 50mg  | Purity Not Available

Adooq Bioscience

LX 1606 is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity.

More Information Supplier Page

LX 1606 5mg 5mg  | Purity Not Available

Adooq Bioscience

LX 1606 is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity.

More Information Supplier Page

LX 1606 100mg 100mg  | Purity Not Available

Adooq Bioscience

LX 1606 is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity.

More Information Supplier Page

LX 1606 10mg 10mg  | Purity Not Available

Adooq Bioscience

LX 1606 is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity.

More Information Supplier Page

SL251188 10mg 10mg  | Purity Not Available

Adooq Bioscience

SL-251188, an oxazolidinone derivative, was characterized in baboons as a radioligand for the in vivo visualization of MAO-B using positron emission tomography (PET).

More Information Supplier Page

LY2811376 50mg 50mg  | Purity Not Available

Adooq Bioscience

LY2811376 is the first orally available non-peptidic BACE1 inhibitor that produces profound A??-lowering effects in animals.

More Information Supplier Page

LY2811376 5mg 5mg  | Purity Not Available

Adooq Bioscience

LY2811376 is the first orally available non-peptidic BACE1 inhibitor that produces profound A??-lowering effects in animals.

More Information Supplier Page